Autobio Diagnostics Co (SHSE:603658) Shares Outstanding (EOP): 571 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603658 Autobio Diagnostics Co Ltd SHSE:603658
95 GF Score
Price ¥32.67
GF Value ¥40.43
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Autobio Diagnostics Co Shares Outstanding (EOP)?

Autobio Diagnostics Co SHSE:603658 -2.21% 95 Shares Outstanding (EOP) is 571 Mil as of Jun. 2026. GuruFocus rates SHSE:603658 with a GF Score™ of 95/100 and a GF Value™ of ¥40.43 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Autobio Diagnostics Co's shares outstanding for the quarter that ended in Jun. 2026 was 571 Mil.

Autobio Diagnostics Co's quarterly shares outstanding stayed the same from Mar. 2026 (571 Mil) to Jun. 2026 (571 Mil).

Autobio Diagnostics Co's annual shares outstanding declined from Dec. 2024 (581 Mil) to Dec. 2025 (571 Mil). It means Autobio Diagnostics Co bought back shares from Dec. 2024 to Dec. 2025 .


Autobio Diagnostics Co  (SHSE:603658) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Autobio Diagnostics Co Shares Outstanding (EOP) Related Terms


Autobio Diagnostics Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Autobio Diagnostics Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Autobio Diagnostics Co Shares Outstanding (EOP) Chart

Autobio Diagnostics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 586.27 586.27 586.27 581.01 571.43

Autobio Diagnostics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 571.43 571.43 571.43 571.43 571.43

SHSE:603658 vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Autobio Diagnostics Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Shares Outstanding (EOP) falls into.


SHSE:603658
95GF Score
Autobio Diagnostics Co Ltd SHSE:603658
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Autobio Diagnostics Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 571 Mil mean?
Autobio Diagnostics Co (SHSE:603658) has a Shares Outstanding (EOP) of 571 Mil as of Jun. 2026. The total shares a company has outstanding, at period-end. View historical data on Autobio Diagnostics Co and its competitors.
Is Autobio Diagnostics Co's Shares Outstanding (EOP) too high?
Autobio Diagnostics Co's current Shares Outstanding (EOP) is 571 Mil. Overall, Autobio Diagnostics Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Autobio Diagnostics Co's Shares Outstanding (EOP) compare to ABT and SYK?
Autobio Diagnostics Co's Shares Outstanding (EOP) of 571 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Autobio Diagnostics Co and its competitors. Autobio Diagnostics Co's current Shares Outstanding (EOP) is 571 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autobio Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Autobio Diagnostics Co (SHSE:603658) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥40.43, compared to a current price of ¥32.67 — trading 19.2% below its estimated fair value. The current Shares Outstanding (EOP) is 571 Mil. Autobio Diagnostics Co's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Autobio Diagnostics Co (SHSE:603658), the current Shares Outstanding (EOP) is 571 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Autobio Diagnostics Co (SHSE:603658) Overvalued in 2026?

Based on GuruFocus' analysis, Autobio Diagnostics Co stock appears to be undervalued. The current stock price of ¥32.67 is trading 19.2% below its estimated GF Value™ of ¥40.43. GuruFocus considers Autobio Diagnostics Co to be Modestly Undervalued.

Key valuation signals for SHSE:603658:

  • Shares Outstanding (EOP): 571 Mil
  • GF Value™: ¥40.43 vs. price of ¥32.67 (19.2% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Autobio Diagnostics Co Business Description

Address No. 199, Jingkai 15th Street, Economic and Technological Development Zone, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, and sales of in vitro diagnostic reagents and instruments. The company's main products include immunoassay, microbiological, molecular diagnostic, and biochemical reagents, along with immunoassay, microbiological, molecular detection, and mass spectrometry instruments, as well as auxiliary testing devices.
95GF Score

Get the complete analysis for SHSE:603658

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.67
Price
¥40.43
GF Value